BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12554073)

  • 1. The influence of lipid nanocapsule composition on their size distribution.
    Heurtault B; Saulnier P; Pech B; Venier-Julienne MC; Proust JE; Phan-Tan-Luu R; Benoît JP
    Eur J Pharm Sci; 2003 Jan; 18(1):55-61. PubMed ID: 12554073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.
    Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP
    Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion.
    Anton N; Gayet P; Benoit JP; Saulnier P
    Int J Pharm; 2007 Nov; 344(1-2):44-52. PubMed ID: 17592746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology.
    Shah RB; Zidan AS; Funck T; Tawakkul MA; Nguyenpho A; Khan MA
    Int J Pharm; 2007 Aug; 341(1-2):189-94. PubMed ID: 17521836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entrance effects at nanopores of nanocapsules functionalized with poly(ethylene glycol) and their flow through nanochannels.
    Popa R; Vrânceanu M; Nikolaus S; Nirschl H; Leneweit G
    Langmuir; 2008 Nov; 24(22):13030-6. PubMed ID: 18950201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of polyethylene glycol 660 12-hydroxy stearate at a triglyceride/water interface.
    Heurtault B; Saulnier P; Pech B; Proust JE; Benoît JP
    Int J Pharm; 2002 Aug; 242(1-2):167-70. PubMed ID: 12176240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural investigations on lipid nanoparticles containing high amounts of lecithin.
    Schubert MA; Harms M; Müller-Goymann CC
    Eur J Pharm Sci; 2006 Feb; 27(2-3):226-36. PubMed ID: 16298113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function.
    Holm R; Jensen IH; Sonnergaard J
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1025-32. PubMed ID: 17012115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, characterization, and in vitro cellular inhibition and uptake of optimized genistein-loaded NLC for the prevention of posterior capsular opacification using response surface methodology.
    Zhang W; Li X; Ye T; Chen F; Sun X; Kong J; Yang X; Pan W; Li S
    Int J Pharm; 2013 Sep; 454(1):354-66. PubMed ID: 23876384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process.
    Salmaso S; Elvassore N; Bertucco A; Caliceti P
    J Pharm Sci; 2009 Feb; 98(2):640-50. PubMed ID: 18484622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of vitamin E-enriched nanoemulsions: factors affecting particle size using spontaneous emulsification.
    Saberi AH; Fang Y; McClements DJ
    J Colloid Interface Sci; 2013 Feb; 391():95-102. PubMed ID: 23116862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of solid lipid nanoparticles containing silibinin.
    Zhang JQ; Liu J; Li XL; Jasti BR
    Drug Deliv; 2007 Aug; 14(6):381-7. PubMed ID: 17701527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug solubilisation in lipid nanoparticles containing high melting point triglycerides.
    Wasutrasawat P; Al-Obaidi H; Gaisford S; Lawrence MJ; Warisnoicharoen W
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):365-71. PubMed ID: 23688806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug.
    Li P; Hynes SR; Haefele TF; Pudipeddi M; Royce AE; Serajuddin AT
    J Pharm Sci; 2009 May; 98(5):1750-64. PubMed ID: 18781639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different polysorbates on development of self-microemulsifying drug delivery systems using medium chain lipids.
    Shah A; Thool P; Sorathiya K; Prajapati H; Dalrymple D; Serajuddin ATM
    Drug Dev Ind Pharm; 2018 Feb; 44(2):215-223. PubMed ID: 29057677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion.
    Khoee S; Yaghoobian M
    Eur J Med Chem; 2009 Jun; 44(6):2392-9. PubMed ID: 19010570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of solid lipid nanoparticles by microemulsion technique].
    Mao SR; Wang YZ; Ji HY; Bi DZ
    Yao Xue Xue Bao; 2003 Aug; 38(8):624-6. PubMed ID: 14628457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of nanostructured lipid carriers containing salicyclic acid for dermal use based on the Quality by Design method.
    Kovács A; Berkó S; Csányi E; Csóka I
    Eur J Pharm Sci; 2017 Mar; 99():246-257. PubMed ID: 28012940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion.
    Hung CF; Fang CL; Liao MH; Fang JY
    Int J Pharm; 2007 Apr; 335(1-2):193-202. PubMed ID: 17129692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
    Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
    Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.